171 related articles for article (PubMed ID: 12031320)
1. Novel bicyclic oxazolone derivatives as anti-angiogenic agents.
Perron-Sierra FM; Pierré A; Burbridge M; Guilbaud N
Bioorg Med Chem Lett; 2002 Jun; 12(11):1463-6. PubMed ID: 12031320
[TBL] [Abstract][Full Text] [Related]
2. Investigation of novel fumagillin analogues as angiogenesis inhibitors.
Pyun HJ; Fardis M; Tario J; Yang CY; Ruckman J; Henninger D; Jin H; Kim CU
Bioorg Med Chem Lett; 2004 Jan; 14(1):91-4. PubMed ID: 14684305
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.
Lee HW; Cho CS; Kang SK; Yoo YS; Shin JS; Ahn SK
Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1024-9. PubMed ID: 17603194
[TBL] [Abstract][Full Text] [Related]
4. 7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase.
Balzarini J; Gamboa AE; Esnouf R; Liekens S; Neyts J; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
FEBS Lett; 1998 Oct; 438(1-2):91-5. PubMed ID: 9821965
[TBL] [Abstract][Full Text] [Related]
5. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis by THAM-derived cotelomers endowed with thalidomide moieties.
Périno S; Contino-Pépin C; Satchi-Fainaro R; Butterfield C; Pucci B
Bioorg Med Chem Lett; 2004 Jan; 14(2):421-5. PubMed ID: 14698173
[TBL] [Abstract][Full Text] [Related]
7. A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances.
Hazel SJ
J Lab Clin Med; 2003 Mar; 141(3):217-28. PubMed ID: 12624603
[TBL] [Abstract][Full Text] [Related]
8. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
Lu J; Chong CR; Hu X; Liu JO
J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel fumagillin and ovalicin analogues.
Mazitschek R; Huwe A; Giannis A
Org Biomol Chem; 2005 Jun; 3(11):2150-4. PubMed ID: 15917904
[TBL] [Abstract][Full Text] [Related]
10. Homology modeling and calculation of the cobalt cluster charges of the Encephazlitozoon cuniculi methionine aminopeptidase, a potential target for drug design.
Bontems F; le Floch P; Duffieux F; Biderre C; Peyret P; Lallemand JY
Biophys Chem; 2003 Aug; 105(1):29-43. PubMed ID: 12932577
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
Sihn G; Walter T; Klein JC; Queguiner I; Iwao H; Nicolau C; Lehn JM; Corvol P; Gasc JM
FEBS Lett; 2007 Mar; 581(5):962-6. PubMed ID: 17316624
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol.
Jeong BS; Choi NS; Ahn SK; Bae H; Kim HS; Kim D
Bioorg Med Chem Lett; 2005 Aug; 15(15):3580-3. PubMed ID: 15978809
[TBL] [Abstract][Full Text] [Related]
13. QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction.
Mekapati SB; Hansch C
Bioorg Med Chem; 2001 Dec; 9(12):3225-30. PubMed ID: 11711298
[TBL] [Abstract][Full Text] [Related]
14. Osteocalcin is angiogenic in vivo.
Cantatore FP; Crivellato E; Nico B; Ribatti D
Cell Biol Int; 2005 Jul; 29(7):583-5. PubMed ID: 15979904
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of a series of novel fumagillin analogues.
Fardis M; Pyun HJ; Tario J; Jin H; Kim CU; Ruckman J; Lin Y; Green L; Hicke B
Bioorg Med Chem; 2003 Nov; 11(23):5051-8. PubMed ID: 14604668
[TBL] [Abstract][Full Text] [Related]
16. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor-induced angiogenesis in the chick embryo chorioallantoic membrane: an electron microscopy study.
Ribatti D; Nico B; Bertossi M; Roncali L; Presta M
Microvasc Res; 1997 Mar; 53(2):187-90. PubMed ID: 9143552
[No Abstract] [Full Text] [Related]
18. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2.
Han CK; Ahn SK; Choi NS; Hong RK; Moon SK; Chun HS; Lee SJ; Kim JW; Hong CI; Kim D; Yoon JH; No KT
Bioorg Med Chem Lett; 2000 Jan; 10(1):39-43. PubMed ID: 10636239
[TBL] [Abstract][Full Text] [Related]
20. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
